@article {1549007,
	title = {Orbital disease in neuro-ophthalmology},
	journal = {Curr Opin Ophthalmol},
	volume = {31},
	number = {6},
	year = {2020},
	month = {2020 Nov},
	pages = {469-474},
	abstract = {PURPOSE OF REVIEW: Orbital disease represents a diverse spectrum of pathology and can result in a variety of neuro-ophthalmic manifestations. The aim of this review is to provide updates on recent advances in our understanding of orbital disease secondary to thyroid eye disease, myositis, IgG4-related disease, sarcoidosis, granulomatosis with polyangiitis and various tumours. RECENT FINDINGS: With regards to thyroid eye disease, there have been recent advances in the development of steroid-sparing therapies, new modalities for objectively monitoring disease activity and increased understanding of the role of environmental risk factors. There has been interest in characterizing the clinical course and underlying mechanism of optic nerve disease secondary to orbital disorders, which has led to advances in how we monitor for and prevent permanent vision loss. Increased knowledge of orbital tumour subtype histopathology and the development of novel classification systems has had prognostic value and aided medical decision-making. SUMMARY: Orbital disease occurs secondary to a wide variety of diseases and can lead to neuro-ophthalmic manifestations with significant morbidity. Advances in our understanding of different subtypes of orbital disease have improved our ability to treat these potentially debilitating conditions.},
	keywords = {Humans, Ophthalmology, Optic Nerve Diseases, Orbital Diseases, Prognosis, Systemic Vasculitis},
	issn = {1531-7021},
	doi = {10.1097/ICU.0000000000000699},
	author = {Dohlman, Jenny C and Cestari, Dean M and Freitag, Suzanne K}
}
